Slide 1
Disruptive research to improve brain
tumour outcomes
Slide 2
Risk free solutions for all brain
tumour patients
Slide 3
Blockchain technology for clinical information management
next arrow
previous arrow

Revolutionizing Brain Cancer Diagnosis and Treatment

dividerr
focus-icon-new

Focus

Disruptive research in minimally invasive brain cancer diagnostics and therapeutics

science

Science

Single Cell multinomic approaches to answer the most demanding questions in neuro-oncology research

Technology

Technology

Blockchain based auditable distributed ledgers to collect and manage all clinical information

Business-Model

Products

Clinician lead products to address specific needs in current care pathway

Artificial-Intelligence

Artificial Intelligence

Proprietary AI/ML algorithms trained on large databases for near perfect precision

Alliances

Alliances

Geographically agnostic cloud based models allowing worldwide access and infinite scalability

Our Science

dividerr

Introducing Liquid Biopsy, a minimally invasive diagnostic tool for brain tumours using a few drops of blood

flow-3

Changing The Paradigm

dividerr
Changing-The-Paradigm-image-dark

Partners

dividerr

Partnerships

dividerr

In addition to our assosiation with the largest hospital chains in India, Exsegen is also a member of the Global Brain Liquid Biposy Consortium which is at the forefront of the global effort in standardizing the use of liquid biopsy in brain tumours.

partnerships
clinical-image2

Ongoing Clinical Trials

dividerr

Exsegen is conducting clinical trials to diagnose brain lesions with a specificity and sensitivity approaching a traditional biopsy in any patient having a radiological lesion that may represent a brain tumour. Further details on our CTRI approved clinical trials can be accessed using the link below

Our Products

dividerr

Exsegen’s product pipeline embraces the transformational advantages of Liquid Biopsy and deep tech platforms. We are in the process of developing new products to improve brain tumour patient outcomes.

image-our-product
slide-3

Elsy, Our Clinical Management Solution

dividerr

ELSY represents a technology solution that has the potential to revolutionise the way clinical trials are conducted. ELSY is designed to increase transparency and accountability in the trial process, from study design and protocol development to data collection and analysis. ELSY can potentially reduce study costs by eliminating manual processes, reducing errors and delays, and improving overall efficiency.

Meet The Team

dividerr
Amit-BW

Dr. Amitava 
Ray

Founder & CEO

Surya-BW

Surya
Madiraju

Co-Founder & Director

Kiran-BW

Kiran
Prathapa

CTO

Vikas-BW

Vikas
Pawar

COO

moona-bw-image

Moona
Chauhan

VP, Sales & Marketing

Yashoda-Ghanekar-BW

Yashoda
Ghanekar, PhD

VP, Science

Subhashini

Subhashini
Sadasivam, PhD

VP, Science

Pallavi-bw-image

Pallavi
Goel, PhD

Bio-Tech Specialist

Vijay-Laxmi-Roy

Vijay
Laxmi Roy

Research Analyst

Vijay-Sreegiriraju-BW

Vijay
Sreegiriraju

VP, Technology

Advisors

dividerr
Amit-Sircar

Amit
Sircar

Goutam-Bhattacharyya-BW

Goutam
Bhattacharyya, PhD

Jyoti-Sagar-image

Jyoti
Sagar

Partha-Mazumdar-image-bw

Partha
Mazumdar, PhD

Indrajeet-Kaur-image-bw

Indrajeet
Kaur, PhD

Publications & Posters

dividerr

Our technical publications are a critical component of our strategy for staying at the forefront of thought leadership in the Brain cancer research. By sharing our research findings and technical expertise with the broader scientific community, we want to continue to innovate and grow knowledge in the years to come.

unseen-studio-s9CC2SKySJM-unsplash
publications-image

Careers

dividerr

We appreciate your interest in joining our growing team. Please send your resume to hr@exsegen.com

FIND US

Level 3, Nirvanaz, Plot No 240
Road No. 36, Jubilee Hills
Hyderabad - 500033
Telangana, India

FOLLOW US
CONTACT US

info@exsegen.com